ENTRY       C06911                      Compound
NAME        Cisplatin;
            cis-Diamminedichloroplatinum(II);
            [PtCl2(NH3)2];
            CDDP
FORMULA     PtCl2(NH3)2
EXACT_MASS  298.9556
MOL_WEIGHT  300.051
REMARK      Same as: D00275
BRITE       Carcinogens [BR:br08008]
             Group 2A: Probably carcinogenic to humans
              Compounds
               C06911  Cisplatin
            Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XA Platinum compounds
                 L01XA01 Cisplatin
                  D00275  Cisplatin (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D00275  Cisplatin (JP16/USP/INN)
            Antineoplastics [BR:br08308]
             Alkylating agents
              Platinum compounds
               Cisplatin
                D00275  Cisplatin (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00275  Cisplatin
DBLINKS     CAS: 15663-27-1
            PubChem: 9128
            ChEBI: 27899
            PDB-CCD: CPT
            NIKKAJI: J277.914E
ATOM        5
            1   Z   Pt   28.6036  -22.2953
            2   X   Cl   30.9906  -20.9285
            3   X   Cl   30.9906  -23.6622
            4   N0  N    25.2000  -20.8600
            5   N0  N    25.2000  -23.5900
BOND        2
            1     1   2 1
            2     1   3 1
///
